Abbott Laboratories (NYSE:ABT) Issues FY 2025 Earnings Guidance

Abbott Laboratories (NYSE:ABT – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 5.050-5.250 for the period, compared to the consensus EPS estimate of 5.160. The company issued revenue guidance of -. Abbott Laboratories also updated its Q1 2025 guidance to 1.050-1.090 EPS. […]

Leave a Reply

Your email address will not be published.

Previous post Reeves puts growth first in clash over net zero and Heathrow expansion
Next post Magnus Financial Group LLC Buys 805 Shares of Invesco S&P 500 Equal Weight ETF (NYSEARCA:RSP)